Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical company headquartered in Australia, focused on developing therapies for neurological disorders. The company specializes in neurodevelopmental disorders such as Rett syndrome, Fragile X syndrome, and other conditions associated with cognitive and social impairments. Neuren's core products include investigational drugs like trofinetide, aimed at improving the quality of life for individuals with these challenging disorders.